International Journal of Hematology and Oncology
2023, Vol 33, Num 4 Page(s): 149-152
| Back | Table of Contents | Turkish Abstract | PDF | Mail to Author | |
DAUNORUBICIN INDUCED BLUE-GRAY HYPERPIGMENTATION: A CASE REPORT
Orhan AYYILDIZ1, Dede ŞİT2, Murat SÖKER3, A. Kemal KADİROĞLU2, A. Haluk YEŞİLBAĞDAN2
1Dicle Üniversitesi Tıp Fakültesi Hematoloji Bilim Dalı
2Dicle Üniversitesi Tıp Fakültesi Nefroloji Bilim Dalı
3Dicle Üniversitesi Tıp Fakültesi Pediatri Anabilim Dalı, DİYARBAKIR
Keywords: Daunorubicin, Blue-gray pigmentation
Daunorubicin is used widely in the treatment of acute myeloblastic leukemia (AML). Daunorubicin has some toxicity which limit the usage of drug. Blue-gray pigmentation is an uncommon side effect of daunorubicin. It is one of the side effect which might disturb patient for a long time cosmetically. We report here a hyperpigmentation case with acute myelomonocytic leukemia who is still on the treatment.
Orhan AYYILDIZ1, Dede ŞİT2, Murat SÖKER3, A. Kemal KADİROĞLU2, A. Haluk YEŞİLBAĞDAN2
1Dicle Üniversitesi Tıp Fakültesi Hematoloji Bilim Dalı
2Dicle Üniversitesi Tıp Fakültesi Nefroloji Bilim Dalı
3Dicle Üniversitesi Tıp Fakültesi Pediatri Anabilim Dalı, DİYARBAKIR
Keywords: Daunorubicin, Blue-gray pigmentation
Daunorubicin is used widely in the treatment of acute myeloblastic leukemia (AML). Daunorubicin has some toxicity which limit the usage of drug. Blue-gray pigmentation is an uncommon side effect of daunorubicin. It is one of the side effect which might disturb patient for a long time cosmetically. We report here a hyperpigmentation case with acute myelomonocytic leukemia who is still on the treatment.
| Back | Table of Contents | Turkish Abstract | PDF | Mail to Author | |